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Abstract
AIM: To screen for genes related to metabotropic re-
ceptors that might be involved in the development of 
chronic hepatitis. 
METHODS: Assessment of 20 genes associated with 
metabotropic receptors was performed in liver speci-
mens obtained by punch biopsy from 12 patients with 
autoimmune and chronic hepatitis type B and C. For 
this purpose, a microarray with low integrity grade 
and with oligonucleotide DNA probes complementary 
to target transcripts was used. Evaluation of gene ex-
pression was performed in relation to transcript level, 
correlation between samples and grouping of clinical 
parameters used in chronic hepatitis assessment. Clini-
cal markers of chronic hepatitis included alanine and 
aspartate aminotransferase, γ-glutamyltranspeptidase, 
alkaline phosphatase and cholinesterase activity, levels 
of iron ions, total cholesterol, triglycerides, albumin, 
glucose, hemoglobin, platelets, histological analysis of 
inflammatory and necrotic status, fibrosis according to 
METAVIR score, steatosis, as well as anthropometric 
body mass index, waist/hip index, percentage of adi-
pose tissue and liver size in ultrasound examination. 
Gender, age, concomitant diseases and drugs were 
also taken into account. Validation of oligonucleotide 
microarray gene expression results was done with the 
use of quantitative real-time polymerase chain reaction 
(qRT-PCR). 
RESULTS: The highest (0.002 < P  < 0.046) expres-
sion among genes encoding main components of 
metabotropic receptor pathways, such as the α subunit 
of G-coupled protein, phosphoinositol-dependent pro-
tein kinase or arrestin was comparable to that of an-
giotensinogen synthesized in the liver. Carcinogenesis 
suppressor genes, such as chemokine ligand 4, tran-
scription factor early growth response protein 1 and 
lysophosphatidic acid receptor, were characterized by 
the lowest expression (0.002 < P < 0.046), while the 
factor potentially triggering hepatic cancer, transcrip-
tion factor JUN-B , had a 20-fold higher expression. The 
correlation between expression of genes of protein 
kinases PDPK1, phosphoinositide 3-kinase and protein 
kinase A (Spearman’s coefficient range: 0.762-0.769) 
confirmed a functional link between these enzymes. 
Gender (P = 0.0046) and inflammation severity, mea-
sured by alanine aminotransferase activity (P = 0.035), 
were characterized by diverse metabotropic receptor 
gene expression patterns. The Pearson’s coefficient 
ranging from -0.35 to 0.99 from the results of qRT-PCR 
and microarray indicated that qRT-PCR had certain 
4156
World J Gastroenterol  2012 August 21; 18(31): 4156-4161
 ISSN 1007-9327 (print)  ISSN 2219-2840 (online)




August 21, 2012|Volume 18|Issue 31|WJG|www.wjgnet.com
Cieśla A et al . Metabotropic receptors in chronic hepatitis
limitations as a validation tool for oligonucleotide mi-
croarray studies.
CONCLUSION: A microarray-based analysis of hepa-
tocyte metabotropic G-protein-related gene expression 
can reveal the molecular basis of chronic hepatitis. 
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
The natural course of  chronic viral hepatitis is affected 
by progression of  fibrosis and the risk of  hepatocellular 
carcinoma development[1]. Current data indicate that 
intracellular signaling disturbances have an impact on 
progression of  inflammation and fibrosis, as well as car-
cinogenesis, in the course of  chronic hepatitis.
G-protein-coupled receptors (GPCRs) are a family 
of  cell surface receptors which receive, integrate and en-
hance the majority of  extracellular signals. After stimula-
tion with different signals, GPCRs activate amplifying 
enzymatic cascades, regulatory proteins and ion chan-
nels. This activation regulates cellular responses, includ-
ing growth, proliferation, and cell survival.
In the present study, using microarray DNA analysis, 
we attempt to define genes related to metabotropic re-
ceptors associated with progression of  chronic hepatitis. 
DNA technology with genomic profiling and cluster 
analysis allows determination of  the role of  genes in the 
pathogenesis of  liver injury[2]. We assessed the activity 
of  20 genes encoding metabotropic receptors, some of  
which have been documented to have probable signifi-
cance in the progression of  chronic hepatitis.
The assessment of  expression of  genes of  the main 
component of  GPCR, such as the G-protein α subunit 
(GNAS), 3-phosphoinositide-dependent protein ki-
nase-1 (PDPK1), phosphoinositide 3-kinase (PIK3CG), 
protein kinase A (AKT1) and arrestin β (ARRB2) was 
performed. We determined transcription factor JUN-B, 
ETS-domain protein (ELK4), early growth response 
protein 1 (EGR1) activated as the result of  GPCR stimu-
lation, angiotensinogen (AGT), which is a GPCR-ligand, 
dual-specificity protein phosphatases 14 (DUSP14), 
which is responsible for dephosphorylation of  kinase 
products, calcitonin receptor proteins (CALCR), thy-
rotropin receptor (TSHR), colony stimulating factor-3 
(CSF3), sphingosine-1-phosphate receptor 1 (EDG1), 
and lysophosphatidic acid receptor (EDG2) associated 
with G-protein. The selection of  EDG2, EGR1, JUN-B, 
chemokine (C-C motif) ligand 4 (CCL4), ELK4 genes 
was based on their association with cellular proliferation, 
differentiation and apoptosis[3-6]. Additionally, the se-
lected group represented genes involved in regulation of  
inflammatory response and liver fibrosis, which included 
genes for interleukin 1β (IL-1β ) and its receptors IL1 
type Ⅰ (IL1R1), IL1 type Ⅱ (IL1R2), CALCR, EDG1, 
CCL4, AGT and adhesion molecules vascular cell adhe-
sion molecule 1 (VCAM1)[7-14].
MATERIALS AND METHODS
In the group of  12 patients (7 men, 5 women; age 36 ± 
10.8 years) with chronic hepatitis type B (2 patients) and C 
(8 patients) and autoimmune hepatitis (2 patients), accord-
ing to clinical indications, a liver biopsy was performed by 
the Menghini technique. From the obtained liver sections, 
a sample of  2-3 mm in length was frozen at -75 ℃ until 
the analysis of  mRNA of  20 selected genes was performed 
(gene list Figure 1). During the histopathological investiga-
tion of  the biopsies, the degree of  inflammation and fibro-
sis was assessed by the METAVIR score and steatosis by 
the steatosis scoring system.
On the day of  liver biopsy, the activity of  serum alanine 
aminotransferase (ALT/GPT Cobas, Roche Diagnostics, 
Mannheim, Germany), aspartate aminotransferase (ASPAT/
GOT Cobas), γ-glutamyltransferase (GGT Cobas), alkaline 
phosphatase (ALP Cobas), cholinesterase (CHE Cobas), the 
level of  iron (Fe Cobas), total cholesterol (CHOD-PAP Co-
bas), triglycerides (TG Cobas), albumin (ALB plus Cobas), 
glucose (GLU Cobas), hemoglobin and platelet (Sysmex 
XE-2100, Sysmex Europe GMBH, Norderstedt, Germany) 
were assessed. Anthropometric measurements, including 
body mass index, waist/hip index and the percentage of  
fatty mass was assessed by skin fold thickness. The size of  
the liver was measured during ultrasound examination of  
the abdomen. Patient characteristics included the presence 
of  concomitant illnesses, drug history, as well as the use 
of  such substances as alcohol and cigarettes (Figure 2). In 
women, the menstrual cycle phase and menopause were 
taken into account. Biochemical, histological and anthropo-
metric parameters are presented in Figure 2. The gene ex-
pression studies were performed using microarray (with low 
integration level), with DNA oligonucleotides complemen-
tary to the investigated transcripts. Total RNA was isolated 
from liver samples using the TRI Reagent (Sigma-Aldrich, 
St. Louis, United States), and then purified using the RNeasy 
MiniElute spin columns with a DNA eliminator (Qiagen, 
Hilden, Germany). The quantity of  isolated RNA was as-
sessed by a spectrophotometer (NanoDrop, Wilmington, 
United States), and subsequently its degradation level was 
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measured by a capillary electrophoresis system (Experion, 
Bio-Rad, Hercules, United States). For further analysis 
only samples without evidence of  RNA degradation were 
qualified (RQI > 8.5 Rna Quality Index). Subsequently, 
based on the obtained RNA, probes were synthesized ac-
cording to the manufacturer’s instructions (SABiosciences, 
Frederick, United States), and then hybridized to a micro-
array. We used the Oligo GEArray Human GPCR Signal-
ing Pathway Finder Microarray (OHS-071) supplied by 
SABioscences. Detection of  the array probes is achieved 
based on chemiluminescence, using the FujiLAS System 
(FujiFilm, Tokyo, Japan). The resulting images (the signal 
density) were quantified using the OligoAnalyser (SA-
Biosciences). The obtained results describing the relative 
levels of  gene expression (with respect to the reference 
gene) were further examined.
Diversification in gene expression was assessed by 
agglomerative hierarchical clustering methods. Using the 
Spearman’s rank correlation coefficient for activity of  the 
investigated genes, we searched for pairs of  objects and 
then for clusters with the smallest distance (Figure 1). An 
analogous classification was carried out using biochemi-
cal, histological and anthropometric parameters (Figure 2). 
Determination of  a direct correlation between gene ex-
pression and clinical features was done based on agglom-
erative hierarchical clustering of  both the investigated 
indicators of  chronic hepatitis. The genotype-phenotype 
distinction was analyzed using Fisher’s exact test, to de-
termine the difference between clustering of  patients 
achieved on the basis of  a dendrogram of  clinical signs 
and a dendrogram of  gene expression (Figures 1 and 2). 
Differentiation of  clinical parameters between groups of  
patients with the biggest difference in gene expression 
was performed by the Mann-Whitney U test and Fisher’s 
exact test. In the present study, these were patients num-
ber 2, 10, 9, 7 vs the rest (Figure 1). The Wilcoxon signed-
rank test was used to assess differential expression be-
tween the selected genes, to determine the three groups 
of  genes with the highest, moderate, and lowest activity 
(Figure 3). 
The results of  the microarray experiment were veri-
fied by means of  quantitative real-time polymerase chain 
reaction (qRT-PCR) for IL1B, VCAM1, PIK3CG , 
AGT, PDPK1, GNAS, JUN-B, EDG2, CCL4, EGR1, 
IL1R1, IL1R2, CALCR, AKT1 and ARRB2. Total 
RNA acquired from the tissues of  interest was reverse-
transcribed using the High-Capacity cDNA Archive Kit 
(Applied Biosystems, Foster City, United States) for the 
2-step qRT-PCR assays. The qRT-PCR was performed 
on a Chromo 4 (Bio-Rad), using the ABI SYBR Green 
master mix (Applied Biosystems). Primer sets against 
sequences of  genes are indicated by microarray. They 
are commercially available at OriGene (Rockville, United 
States), but were additionally checked for specificity with 
National Center for Biotechnology Information (NCBI) 
The Basic Local Alignment Search Tool (BLAST). The 
optimum annealing temperature for each primer set was 
determined prior to the analysis of  experimental sam-
ples. Following amplification, dissociation curves were 
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Figure 1  Agglomerative hierarchical clustering methods of genes ex-
pression. The dendrogram assigned to the numerical value on the horizontal 
axis describes the patients’ correlation; the dendrogram assigned to individual 
genes on the vertical axis describes the genes’ correlation. Figures on the 
x-axis denote patient order. VCAM1: Vascular cell adhesion molecule 1; TSHR: 
Thyroid stimulating hormone receptor; CCL4: Chemokine (C-C motif) ligand 4; 
CALCR: Calcitonin receptor; PDPK1: 3-phosphoinositide-dependent protein 
kinase-1; PIK3CG: Phosphoinositide 3-kinase; IL1β : Interleukin 1β; AKT1: 
Protein kinase A; GNAS: α subunit of G-coupled protein; ARRB2: Arrestin β; 
IL1R1: Interleukin 1 receptor, type Ⅰ; CSF3: Colony stimulating factor-3; ELK4: 
ETS-domain protein; AGT: Angiotensinogen; JUN-B: Transcription factor jun-B; 
IL1R2: Interleukin 1 receptor, type Ⅱ; EDG1: Sphingosine-1-phosphate recep-
tor 1; DUSP14: Dual-specificity protein phosphatases 14; EGR1: Early growth 
response protein 1; EDG2: Lysophosphatidic acid receptor.
Figure 2  Agglomerative hierarchical clustering methods of clinical fea-
tures expression. The dendrogram assigned to a numerical value on the 
horizontal axis describes the patients’ correlation; the dendrogram assigned to 
individual clinical features on the vertical axis describes the clinical features’ 
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analyzed for each reaction. A sample volume of  20 μL 
was used for all assays which contained a 1X final con-
centration of  SYBR green PCR master mix, 100 nmol 
gene specific primers, and 1 μL of  template. The as-
says were run using the following protocol: 95 ℃ for 10 
min, 95 ℃ for 40 s, gene specific annealing temperature 
(58-62 ℃) for 60 s for 40 cycles, followed by a gradual 
increase in temperature from 55 ℃ to 95 ℃ during the 
dissociation stage.
Following amplification, the instrument software 
was used to set the baseline and threshold for each reac-
tion, as well as to determine the reaction efficiency. A 
cycle threshold (Ct) was assigned at the beginning of  the 
logarithmic phase of  PCR amplification and the differ-
ence in the Ct values [corrected for reaction efficiency: 
Ct = Ct × log(efficiency)/log(2)] of  the housekeeping 
genes [mean Ct of  glucuronidase (GUS) and beta-actin 
(BAKT)] and the gene of  interest were used to deter-
mine the relative expression of  the gene in each sample. 
Relative expression levels were then calculated as fold 
changes to the housekeeping genes, where each PCR 
cycle represented a 2-fold change.
The data of  PCR and microarray experiments were 
then correlated using Pearson’s coefficient. 
The study was carried out in accordance with the 
Declaration of  Helsinki (2000) of  the World Medical 
Association.
RESULTS
Using the agglomerative hierarchical clustering methods 
we found statistically significant correlations between the 
EDG1, DUSP14, EGR1 and EDG2 genes and PDPK1, 
PIK3CG, AKT1, as well as clustering, though not sta-
tistically significant, for GNAS and ARRB2 (Figure 1). 
Spearman’s rank correlation coefficients were 0.762 for 
PDPK1 and AKT1, 0.769 (P < 0.05) for PDPK1 and 
PIK3CG, 0.769 (P < 0.05) for AKT1 and PIK3CG, and 
0.699 (P < 0.05) for GNAS and ARRB2. In case of  
EDG1, DUSP14, EGR1 and EDG2, in 10 out of  12 pa-
tients there was no transcriptional activity. Except for the 
transcriptional factor JUN-B and the stage of  fibrosis r 
= 0.667 (P < 0.05), we did not observe any correlation 
between the activity of  the selected genes and the in-
vestigated clinical factors. Assessing patient distribution 
based on dendrograms of  the investigated genotype and 
phenotype, a difference on the border of  statistical sig-
nificance was found in Fisher’s exact test (P = 0.08). The 
patients with the highest diversity in gene expression 
(Figure 1) showed a statistically significant difference in 
gender and ALT activity (P = 0.0046 and P = 0.035, re-
spectively). Based on expression activity, the genes were 
divided into a group with high activity, which included 
GNAS, PDPK1, AGT and ARRB2 and statistically dif-
fered (0.002 < P < 0.046) from the genes with moderate 
and low expression. The group of  genes with moderate 
activity of AKT1, PIK3CG, IL1β , VCAM1, JUN-B and 
CALCR also showed a statistically significant difference 
(0.002 < P < 0.041) compared with genes which were 
classified as belonging to the group with low expression 
(Figure 3). 
For the following genes: JUN-B, EDG2, CCL4 and 
EGR1, estimated with the use of  microarrays and qRT-
PCR, there was a strong positive correlation, with Pearson’s 
coefficient within the range of  0.61-0.99. For other genes, 
IL1B, VCAM1, PIK3CG, AGT, PDPK1, and GNAS, 
the correlation was weakly positive, with Pearson’s coef-
ficient ranging from 0.07 to 0.43; and for IL1R1, IL1R2, 
CALCR, AKT1, and ARRB2 the correlation of  expres-
sion estimated with the two methods was weakly negative 
(Pearson’s coefficient ranging from -0.1 to -0.35).
DISCUSSION
With the exception of  the correlation between JUN-B 
and fibrosis stage, we did not reveal any direct relation-
ship between expression of  genes related to metabo-
tropic receptors in hepatocytes and anthropometric, his-
tological and biochemical parameters that are commonly 
used for monitoring progression of  chronic hepatitis. 
In assessing the connection between gene expression 
and the investigated clinical features, we found an im-
pact of  gender and concentration of  ALT in the serum 
on changes in gene expression. The effect of  these two 
factors was detected as the result of  the analysis of  not 
any single, but rather all the investigated genes. In the 
probability test, it was gender which better determined 
changes in gene activity rather than ALT. In chronic 
hepatitis C and B, gender is the factor which defines the 
course and prognosis of  the disease[1]. Changes in gene 
expression resulting from gender differences can influ-
ence the progression of  liver disease. 
In the present study, among different markers of  
inflammation and fibrosis in the liver parenchyma, only 
the ALT level differentiated the gene activity. Among 
the investigated genes, there were important mediators 
of  inflammation, including IL-1β, with their receptors, 
as well as chemokines and adhesion factors. Also pro-
tein products of  such genes as EDG1, EDG2, CALCR 
are involved in the induction of  the inflammatory re-
sponse[9,15]. In contrast to ALT, a small histological dif-
ference used to assess the inflammatory process in the 
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Figure 3  Arithmetic mean of gene activity. There was a statistically signifi-
cant difference in the Wilcoxon signed-rank test between the genes with the 
highest expression, GNAS, PDPK1, AGT, and ARRB2,  and moderate expres-
sion, PIK3CG, AKT1, IL1β, VCAM1, CALCR, and JUN-B, and between the 
genes with moderate expression and the remaining genes with low expression.









liver, classified in the majority of  cases as score 1 or 2 
according to METAVIR, were not useful in assessing 
gene expression. 
The reported values of  genes expression and their 
statistical diversity allow distinction between three groups 
of  genes with high, moderate and low activity. Because 
there is no direct correlation between gene activity and 
clinical markers of  chronic hepatitis, it is difficult to de-
termine if  the observed gene expression is induced or 
constitutional. 
In the group of  genes with the highest activity there 
were genes of  the main metabotropic receptor proteins, 
GNAS, PDPK1 and ARRB2. Their high transcriptional 
activity is related to their essential role in the metabo-
tropic receptor system. GNAS expression, despite indi-
vidual differences, showed the highest correlation with 
ARRB2 among the investigated genes. Proportional 
to the level of  stimulation of  GPCR, ARRB2 triggers 
the mechanism of  receptor internalization, which is an 
adaptation to overstimulation[16]. Also mRNA encoding 
AGT was characterized by high expression. This obser-
vation remains in accordance with current literature and 
is associated with the liver being the main site of  AGT 
synthesis[17]. Because AGT is incorporated only indirectly 
by the renin-angiotensin system in the progression of  
liver fibrosis[18,19], its gene activity did not correlate with 
the histological assessment of  this process. 
In the group of  genes with moderate activity, there 
were genes which encode products involved in the 
pathogenesis of  liver injury. Disturbances of  PIK3CG 
described in chronic hepatitis as caused by NS5 protein 
of  hepatitis C virus and HBx protein of  hepatitis B virus 
destabilize and damage hepatocytes[20,21]. However, in the 
present study, expression of  PIK3CG did not correlate 
with the markers of  liver injury. 
As there were no cases with advanced fibrosis among 
the investigated patients, we did not observe any in-
creased expression of  VCAM1, which is characteristic 
only for liver cirrhosis[22].
The correlation of  expression of  phosphatidylinosi-
tol kinases observed in the study confirms the functional 
association of  the investigated enzymes. A significantly 
higher expression of  PDPK1 compared with PIK3CG is 
due to the amplification of  PDPK1 during phosphory-
lation catalyzed by PIK3CG. PDPK1 in turn activates 
AKT1 correspondingly; therefore, the 3-fold higher ac-
tivity of  PDPK1 is noteworthy.
Among the investigated phosphatases that dephos-
phorylate active kinases, DUSP14 was measured. How-
ever, this phosphatase, which is not functionally associ-
ated with the presently studied kinases, showed low ex-
pression values and was not correlated with the expres-
sion of  kinases. Interestingly, a statistically significant 
correlation was determined between the stage of  fibrosis 
and expression of  transcriptional factor JUN-B. This 
factor, in the malfunctioning of  the liver, is responsible 
for reprogramming of  hepatocyte genes to the phase of  
cell proliferation[23,24]. Its increase is frequently observed 
in liver injury and hepatic carcinogenesis[25]. 
The higher expression of  this factor linked to car-
cinogenesis correlated with a low activity of  the genes 
CCL4, EGR1, EDG2 involved in the induction of  apop-
tosis and suppression of  neoplasia[26].
The results obtained in the present study indicate 
that qRT-PCR has certain limitations as a validation tool 
for oligonucleotide microarray studies. Only four genes 
have shown a similar expression pattern between results 
obtained with the use of  both techniques. A weak posi-
tive and negative correlation observed for other genes 
might result from potential pitfalls inherent in both ap-
proaches, and might be a source of  errors encountered 
while employing each method. 
However, the range of  differences in the correla-
tion coefficient observed in the present study remains 
within the range described in the literature, from -0.48 
to 0.94[27,28]. The results obtained in this study reflect the 
debate over which methods produce the most accurate 
measurements of  gene expression.
In conclusion, gender and inflammation activity, as 
determined by ALT level, were associated with a more 
diverse pattern of  metabotropic receptor gene expres-
sion. The highest gene expression was observed for 
mRNA of  the main components of  the metabotropic 
receptor pathway, such as GNAS, PDPK1, ARRB2, and 
correlated with mRNA of  angiotensinogen synthesized 
in the liver. The correlation of  expression of  protein ki-
nases PDPK1, PIK3CG and AKT1 points to a functional 
association of  these enzymes. The genes suppressing 
carcinogenesis, CCL4, EGR, EDG2, were characterized 
by the lowest expression levels among the investigated 
genes. On the other hand, JUN-B, a factor potentially in-
volved in the development of  hepatocellular cancer, was 
characterized by a 20-fold higher level of  expression. 
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